Cerba Research has conducted many trials across therapy areas from pre-clinical to phase III and beyond. Notably, the laboratory has contributed to the market authorization and/or expansion of about 120 innovative drugs or formulations.
Infectious Diseases and Vaccine Development
We provide world-class operational expertise, logistical infrastructure and the scientific rigor necessary to effectively characterize, research and treat infectious diseases as they emerge.
We deploy a global team of experts who can use their experience, knowledge and the best available technologies to accelerate clinical trials and ultimately reduce the burden of infectious diseases. We do this empowered by our people, science, and technology and infrastructure.
Infectious Diseases and Vaccines
Virology, bacteriology and vaccine development
Oncology
With increased complexity in oncology protocol design and time sensitivity, we can provide you with an adaptive, specialist oncology team with access to the latest science and technology who will optimise the outcome of your clinical trials. Precision medicine development in the oncology field requires a flexible and agile speciality laboratory partner who can adjust as the protocol does, ensuring endpoints are captured. This will enable studies to move forward with the right data.
Other Therapies
Inflammation & Immunology
The laboratory’s expertise often focuses on the use of state-of-the-art specialty assays such as, cytokines, chemokines, and growth factor panels, 250+ immunohistochemistry (IHC) protocols, next-generation sequencing (NGS) assays, safety testing and more.
Metabolics
Cerba Research has conducted ~60 metabolic disease trials in the past 10 years alone. The laboratory’s expertise extends to indications such as nonalcoholic steatohepatitis (NASH) and type 2 diabetes and includes routine assays, such as HbA1c, in most cases.
Neurosciences
Clinical trial sponsors working in neuroscience indications rely on Cerba Research’s expertise, knowing we can help shorten the time to better therapies with our wide range of specialty and safety testing capabilities performed in blood, serum, tissue and/or cerebral spinal fluids (CSF).
Cross-therapy Areas
Click each area to learn more about our cross-therapy area expertise & capabilities. Get in touch to learn more.
Cell & Gene Therapy
Developing cell and gene therapies requires an increased need to access expertise, knowledge, data and insights to bring the right patient to the right treatment at the right time. We facilitate state-of-the art technology, subject matter expertise, specialised logistics and operations to accelerate cell and gene therapy development.
Cerba Research is your trusted and agile laboratory partner for biologics and biosimilars drug development. Our focus is the development of reliable and robust bioanalytical methods for your drug development program(s).
In the past 5 years, we’ve conducted 190+ rare disease trials, resulting in 36 drug approvals for rare to ultra-rare conditions.
Discover Our Expertise In Transforming Research For Your Therapies
Reach out to our experts and see how we can help advance your clinical trial